Ionis Pharmaceuticals, Inc.

At the American Academy of Allergy, Asthma and Immunology - AAAAI 2025 Annual Meeting, we’ll be sharing new data on our investigational RNA-targeted prophylactic medicine for hereditary angioedema (#HAE) across 11 presentations.     HAE is a genetic #raredisease, characterized by frequent and severe swelling attacks, that impacts the lives of about 20,000 people across Europe and the U.S.     Read more: https://lnkd.in/ebrDkVNR

HAEVN is an online hub developed in collaboration with people living with hereditary angioedema (#HAE) to offer support, connection and inspiration to the HAE community.    Visit HAEVNhub.com to gain insights into the challenges of living with HAE, hear personal stories from community members and access valuable tools and resources.

Familial chylomicronemia syndrome (FCS) is a rare, genetic and potentially life-threatening disease characterized by extremely high triglyceride levels. Hear from Rick about what it’s like #livingwithFCS.

Today, Ionis recognizes International AngelmanDay - a day dedicated to shining a light on #AngelmanSyndrome (AS), a rare genetic disorder, and celebrating people living with AS, their caregivers, siblings and families.    To learn more about International Angelman Day, or download assets to share on your own channels, visit: https://lnkd.in/dqCuzgKy

HAE is a potentially life-threatening genetic condition that involves recurrent attacks of severe swelling (angioedema) in various parts of the body. Test your knowledge about this #raredisease.

You asked an Ion, and Alison Sitt answered. Learn about our recruiting process, employee resource groups, collaborative culture, and more. What else are you wondering about working at Ionis? Ask in the comments below! Visit our career site for more info: https://lnkd.in/dwaMDXr5

The Year of the Snake has begun! Celebrating holidays that represent the diverse backgrounds of our employees is one way we sustain our culture of inclusion and belonging at Ionis. In the zodiac tradition, snakes symbolize transformation and are naturally strategic—qualities we’re embracing for a year of growth and momentum in 2025. How will you embody The Snake this year 🐍?

Familial chylomicronemia syndrome (FCS) is a rare, genetic, and potentially life-threatening disease characterized by extremely high triglyceride levels and, often, a history of pancreatitis. Learn more about FCS at KnowYourTGs.com. #livingwithFCS

Curious about our recruiting process, our offices, our employee resource groups, or our one-of-a-kind culture? Ever wonder what it’s like to work on a team that develops and delivers breakthrough therapies that have the potential to change patients’ lives? You’re in luck! Drop your questions in the comment section below by 1/29, and Alison Sitt, our manager of Talent Acquisition, will spill the beans 2/5 on the Ionis Instagram: https://lnkd.in/dD6zDZZv

 Ionis CEO, Brett P. Monia, PhD, spoke with BiotechTV at #JPM25, providing details about the company’s new chapter as a fully integrated commercial-stage biotech company. Watch his video interview and learn more about what’s to come for Ionis in 2025: https://lnkd.in/g53aHDnE